Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling

• Published in: International journal of molecular sciences 2020-08, Vol.21 (17), p.6115
• Main Authors: Walsh, Kenneth B, Andersen, Haley K
• Format: Article
• Language: English
• Subjects: Action potential; Adenylate cyclase; Adolescent; Animals; Binding; Brand names; Calcium channels; Calcium channels (N-type); Calcium ions; Cannabinoid CB1 receptors; Cannabinoid CB2 receptors; Cannabinoids - chemistry; Cannabinoids - pharmacology; CB1 receptors; cell signaling assays; Channels; Drug abuse; Drug dosages; Forensic science; Forensic toxicology; Humans; Hypothermia; Kinases; Ligands; Male; Marijuana; Models, Molecular; molecular pharmacology; Molecular Structure; Neurotransmitter release; Neurotransmitters; Nonsteroidal anti-inflammatory drugs; Pain perception; Pertussis; Pertussis toxin; Pharmacology; Potassium channels (inwardly-rectifying); Proteins; Receptor, Cannabinoid, CB1 - chemistry; Receptor, Cannabinoid, CB1 - metabolism; Review; Seizures; Signal Transduction - drug effects; Structure-Activity Relationship; synthetic cannabinoids; Tetrahydrocannabinol; THC; Toxicity; Young Adult; Young adults
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21176115

Synthetic cannabinoids (SCs) are a class of new psychoactive substances (NPSs) that exhibit high affinity binding to the cannabinoid CB1 and CB2 receptors and display a pharmacological profile similar to the phytocannabinoid (-)- -Δ -tetrahydrocannabinol (THC). SCs are marketed under brand names such as K2 and Spice and are popular drugs of abuse among male teenagers and young adults. Since their introduction in the early 2000s, SCs have grown in number and evolved in structural diversity to evade forensic detection and drug scheduling. In addition to their desirable euphoric and antinociceptive effects, SCs can cause severe toxicity including seizures, respiratory depression, cardiac arrhythmias, stroke and psychosis. Binding of SCs to the CB1 receptor, expressed in the central and peripheral nervous systems, stimulates pertussis toxin-sensitive G proteins (G /G ) resulting in the inhibition of adenylyl cyclase, a decreased opening of N-type Ca channels and the activation of G protein-gated inward rectifier (GIRK) channels. This combination of signaling effects dampens neuronal activity in both CNS excitatory and inhibitory pathways by decreasing action potential formation and neurotransmitter release. Despite this knowledge, the relationship between the chemical structure of the SCs and their CB1 receptor-mediated molecular actions is not well understood. In addition, the potency and efficacy of newer SC structural groups has not been determined. To address these limitations, various cell-based assay technologies are being utilized to develop structure versus activity relationships (SAR) for the SCs and to explore the effects of these compounds on noncannabinoid receptor targets. This review focuses on describing and evaluating these assays and summarizes our current knowledge of SC molecular pharmacology.